GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 65 filers reported holding GAMIDA CELL LTD in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $247,546 | +1178690.5% | 128,262 | +672.6% | 0.00% | – |
| Q4 2022 | $21 | -100.0% | 16,602 | -88.6% | 0.00% | – |
| Q3 2021 | $573,000 | +2.3% | 146,235 | +67.2% | 0.00% | – |
| Q2 2021 | $560,000 | -67.6% | 87,436 | -59.0% | 0.00% | -100.0% |
| Q1 2021 | $1,726,000 | -14.3% | 213,379 | -11.1% | 0.00% | 0.0% |
| Q4 2020 | $2,015,000 | +145.1% | 240,119 | +21.2% | 0.00% | 0.0% |
| Q3 2020 | $822,000 | -34.0% | 198,186 | -27.3% | 0.00% | -50.0% |
| Q2 2020 | $1,245,000 | +1331.0% | 272,459 | +848.3% | 0.00% | – |
| Q1 2020 | $87,000 | -42.0% | 28,732 | -17.7% | 0.00% | – |
| Q4 2019 | $150,000 | -49.8% | 34,897 | -49.5% | 0.00% | – |
| Q3 2019 | $299,000 | -48.8% | 69,077 | -39.9% | 0.00% | -100.0% |
| Q2 2019 | $584,000 | +167.9% | 115,010 | +505.4% | 0.00% | – |
| Q1 2019 | $218,000 | +3.8% | 18,996 | -9.9% | 0.00% | – |
| Q4 2018 | $210,000 | – | 21,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187 | $107,000,000 | 1.12% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $307,000 | 0.28% |
| Rock Springs Capital Management LP | 2,175,000 | $3,850,000 | 0.11% |
| Platform Technology Partners | 57,625 | $102,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,197,875 | $2,120,000 | 0.05% |
| Guild Investment Management, Inc. | 18,000 | $28,000 | 0.04% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $760,000 | 0.01% |
| 1492 Capital Management LLC | 10,000 | $18,000 | 0.01% |
| ARK Investment Management | 714,534 | $1,558,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,868,896 | $3,308,000 | 0.01% |